Technical analysis of Radiopharm Theranostics Limited (RADX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions.
Price Performance
| 1 month | -36.26% |
| 3 months | -62.47% |
| Year-to-date | -68.01% |
| 1 year | -76.48% |
52-Week Range
| 52-week High | $16.25 |
| 52-week Low | $1.50 |
| Avg Volume (90d) | 66K |
Technical Indicators
| SMA 50 | $2.97 |
| SMA 200 | $4.29 |
| Beta | 0.84 |
| 30-day Volatility (annualised) | 99.8% |
| Price vs SMA 50 | -43.8% |
| Price vs SMA 200 | -61.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $5.26 | |
| 2025-11 | $4.56 | -13.3% |
| 2025-12 | $5.22 | +14.5% |
| 2026-01 | $5.05 | -3.3% |
| 2026-02 | $4.99 | -1.2% |
| 2026-03 | $4.30 | -13.8% |
| 2026-04 | $4.27 | -0.7% |
| 2026-05 | $4.58 | +7.3% |
| 2026-06 | $4.19 | -8.5% |
| 2026-07 | $3.15 | -24.8% |
| 2026-08 | $2.28 | -27.6% |
| 2026-09 | $1.67 | -26.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.67 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | AU |
Valuation Ratios
| Price / Book | 2.21 |
| EV / EBITDA | -1.01 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 1.16 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -2.76 |